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Abstact 
 
 Rocaglamide derivatives are the compounds which have featuring cyclopenta[b]tetra-
hydrobenzofuran skeleton. Until now it includes more than 50 naturally occurring derivatives. 
They were chosen to be interesting candidates for possible therapeutic agents primarily in the 
field of cancer chemotherapy due to their cytotoxic activities data against various cancer cells. 
A quantitative structure activity relationship (QSAR) studies were done to investigate 
physicochemical properties of molecule which contribute to their activities. Series of 
rocaglamide derivatives have been used and analyzed using linear free energy regression 
Hansch model for their cytotoxic activities against MONO-MAC-6 leukemia cells, RAJI 
lymphoma cells and MEL-JUSO melanoma cells. Results showed that the best QSAR equations 
were revealed involving C Log P and CMR parameters with nonlinear regression relationships 
in cytotoxic activities of rocaglamide derivatives against cancer cells above.   
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INTRODUCTION  
 
Natural products are rich source of 
biologically active compound such as Rocaglamide. 
This compound and its naturally occurring congeners 
are tetrahydrobenzofurans that occur exclusively in 
member of genus Aglaia. These natural products are 
believed to have strong insecticidal activity.  
Recently, Rocaglamide derivatives have also been 
found to have an inhibitory effect on the activity of 
the proinflammatory transcription factor NF-κB. 
They are potent immunosuppressive phytochemicals 
that inhibit cytokine gene expression at the 
transcription level such as IFN-γ, TNF-α, IL-2 and 
IL-4 production in peripheral blood T cells at 
nanomolar concentration.  
It is suggested that rocaglamide have potential 
role in the development of drugs against 
inflammation and graft rejection after 
transplantation. Rocaglamide derivatives pronounced 
cytostatic activity against human cancer cell lines 
and also able to elicit apoptosis in resistant tumor 
cells (Proksch, 2005). These data make these 
compounds interesting candidates for possible 
therapeutic agents primarily in the field of cancer 
chemotherapy.  
Quantitative structure activity relationship 
(QSAR) is an important part of drug design, in an 
attempt to get a new drug with greater activity, 
higher selectivity, toxicity or side effects as small as 
possible and greater comfort.  
In addition, by using the QSAR model will be 
more cost-saving or more economical, because to get 
new drugs with the desired activity, try to factor 
suppressed as small as possible so that the path 
becomes shorter synthesis (Siswandono, 2000). 
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QSAR method can be generally defined as an 
application of mathematical and statistical methods 
to the problem of finding empirical relationships 
(QSAR models) of the form Pi = k^ (D1 ,D2 ,...Dn), 
where Pi are biological activities (or other properties 
of interest) of molecules, D1, D2,…,Dn are 
calculated (or, sometimes, experimentally measured) 
structural properties (molecular descriptors) of 
compounds, and  k^ is some empirically established 
mathematical transformation that should be applied 
to descriptors to calculate the property values for all 
molecules. The relationship between values of 
descriptors D and target properties P can be linear or 
non-linear.  
The example of the former relationship is 
given by multiple linear regression (MLR) common 
to Hansch QSAR approach, where target property 
can be predicted directly from the descriptor values. 
The goal of QSAR modeling is to establish a trend in 
the descriptor values, which parallels the trend in 
biological activity. In essence, all QSAR approaches 
imply, directly or indirectly, a simple similarity 
principle, which for a long time has provided a 
foundation for the experimental medicinal 
chemistry: compounds with similar structures are 
expected to have similar biological activities. QSAR 
approach attemps to identify and quantify the 
physicochemical properties of a drug and to see 
whether any of these properties has an effect on the 
drug’s biological activity. By quantifying 
physicochemical properties, it should be possible to 
calculate in advance what the biological activity of a 
novel analogue might be. (Patrick, 2005) 
Hydrophobic character of a drug is crucial to 
how easily it crosses cell membrane and may also be 
important in receptor interactions. Changing 
substituents on a drug may have significant effect on 
its hydrophobic character and hence its biological 
activity. This reflects that the drug must pass through 
the hydrophobic barrier such as cell membranes in 
order to reach the target. Although there is no barrier 
that must be passed (e.g. in vitro studies), drug 
compound must interact with a target system such as 
enzymes or receptors in which the binding site is 
usually active also hydrophobic. In other hand, the 
bulk, size and shape of a drug will influence how 
easily it can approach and interact with a binding 
site. (Patrick, 2005). 
There are several models of QSAR model 
include the Free-Wilson Model, Linear Free Energy 
Regression (LFER) Hansch Model, approach to 
quantum mechanics and molecular connectivity. In 
this research, LFER Hansch approach model will be 
used in the analysis of quantitative structure activity 
relationship rocaglamide derivatives to determine the 
physicochemical properties that influence on 
cytotoxic activity against various cancer cells such 
as MONO-MAC-6, MEL-JUSO and RAJI.  
            
METHODS 
 
In this study we used Notebook with 
specification: Intel core i3, DDR3 2GB + 1 GB, 
HDD 320 GB and Windows 7 operation system. The 
most stable structure of rocaglamide derivatives 
were drawn and then hydrophobicity (Log P and 
Clog P) and steric (MR and CMR) propertie values 
from each compound were obtained theoretically 
using Chembiodraw software program.  
IC50 data of rocaglamide derivatives collected 
from Bohnenstangel (2000). C is the nanomolar 
concentration that inhibit 50% growth of cancer cell; 
log 1/C is the subsequent dependent variable that 
defines the biological parameter for QSAR 
development. 
The properties owned by their respective 
compounds were linked with cytotoxic activity data. 
C log P is the calculated partition coefficient of a 
compound in n-octanol/water and is a measure of its 
hydrophobicity. CMR is the calculated Molar 
refractivity (MR) for the whole molecule. Then, we 
determined the best linear or nonlinear regression 
equation between the properties of hydrophobic and 
steric with cytotoxic activity data from 
Bohmestangel (2000) using SPSS statistic program. 
 
RESULTS 
 
The structure of Rocaglamide derivatives 
were investigated for QSAR analysis in this study 
are shown figure 1. 
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Fig 1. Structure of Rocaglamide Derivatives 
 
Table 1. Side chain substituen of Rocaglamide derivatives [1- 11] 
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Biological activities data and Physicochemical Properties value of Rocaglamide derivatives are shown in Table 
2. 
 
 
Table 2. C log P and CMR value and cytotoxic data of Rocaglamide derivatives 
 
 
Rocaglamide 
 
 
C log P 
 
CMR 
MONO-MAC-6 MEL-JUSO RAJI 
IC50 (nm) Log 1/IC50 IC50 (nm) Log 1/IC50 IC50 (nm) Log 1/IC50 
[1] 2.1476 13.164 4 -0.60 13 -1.11   
[2] 2.1244 13.006 37 -1.57 51 -1.71   
[3] 2.0814 13.317 22 -1.35 31 -1.49 35 -1.54 
[4] 2.4916 13.470 105 -2.02 81 -1.91   
[5] 3.3388 14.434 188 -2.28 164 -2.21   
[6] 2.5782 13.781 32 -1.52 18 -1.25 32 -1.20 
[7] 2.4782 13.934 54 -1.74 40 -1.60 175 -2.24 
[8] 3.4642 14.398 172 -2.22 92 -1.96 187 -2.25 
[9] 3.8356 14.897 82 -1.92 57 -1.77 178 -2.25 
[10] 1.6814 14.862 24 -1.39 22 -1.35 18 -1.26 
[11] 3.172 13.255 242 -2.4 138 -2.15 197 -2.3 
[12] 4.5968 14.531 40 -1.6 32 -1.52   
[13] 
 
2.9222 18.182 4600 -3.7 4600 -3.7   
 
 
Cytotoxic activity against MONO-MAC-6 
leukemia cells 
Based on biological activity data of 
Rocaglamide derivatives against MONO-MAC-6 
cells which derived from dissertation of 
Bohnenstangel (2000) and physicochemical 
properties used to derived QSAR analysis, it is 
determined the quotations above.   
a. a linear regression model 
 
Log 1/C = -0.099 C Log P – 0.375 CMR + 3.75 
  
n = 13;  r = 0.74;  r2 =  0.55;  F = 6.029;  s = 0.54  
 
(1) 
 
b. a nonlinear regression model 
 
Log 1/C = -0.17 (ClogP)2 + 0.57 CLogP + 0.11 CMR – 3.48 
 
n = 13;    r = 0.82;    r2 =  0.67;     F = 6.126;    s = 0.48  
(2) 
 
 
Cytotoxic activity against RAJI lymphoma cells 
Based on biological activity data of 
Rocaglamide derivatives against RAJI lymphoma 
cells from Bohnenstangel (2000) and 
physicochemical properties used to derived QSAR 
analysis, it is determined the quotations above. 
1. a linear regression model 
Log 1/C = -0.57C CLogP – 0.098 CMR – 1.64  
   
n = 7;     r = 0.85;    r2 = 0.72;    F = 5.084;   s = 0.33  
(3) 
 
2. a nonlinear regression model 
Log 1/C = 0.01 (ClogP)2 – 0.614 CLogP + 0.1 CMR –  1.6 
   
n = 7;   r = 0.85;   r
2
 = 0.72;    F = 2.56;   s = 0.38     
 
(4) 
 
Cytotoxic activity against MEL-JUSO 
melanoma cells 
Based on biological activity data of 
Rocaglamide derivatives against MEL-JUSO 
melanoma cells from Dissertation of Bohnenstangel 
(2000) and physicochemical properties used to 
derived QSAR analysis, it is determined the 
quotations above. 
1. a linear regression model 
 
Log 1/C = 0.013 CLogP – 0.363 CMR + 3.314  
 
n = 13;   r = 0.762;   r2 = 0.58;   F = 6.904   s =  0.46 
 
(5) 
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2. a nonlinear regression model 
Log 1/C = -0.2 (ClogP)2 + 0.81 CLogP + 2.1 CMR – 5.22 
   
n = 13;   r = 0.89;   r2 = 0.80;   F = 12.067;   s = 0.33 
 
(6) 
 
DISCUSSION 
 
A quantitative structure–activity relationship 
(QSAR) related numerical properties of the 
molecular structure to its activity by a mathematical 
model. In drug design, QSAR methods have often 
been used to consider qualities beyond in vitro 
potency. A structure-activity study can help to dicide 
which features of a molecule give rise to its overall 
activity and help to modified compounds with 
enhance properties.  
The most widely used technique for deriving 
QSAR equations is linear regression, which uses 
least-quares fitting to find the best combination of 
coefficients in the QSAR equation. In QSAR 
equation, n is the number of data points, r is the 
correlation coefficient between observed values of 
the dependent and the values calculated from the 
equation, r
2
 is the square of the correlation 
coefficient and represent the goodness of fit, F is the 
Fischer statistics (Fischer ratio) and s is the standard 
deviation. The F-value is actually the ratio between 
explained and unexplained variance for a given 
number of degree of freedom. Thus, it indicates a 
true relationship, or the significance level for the 
MRL models. 
Based on QSAR analysis on cytotoxic activity 
against three types of cancer cell lines here, it is 
indicated that there is a relationship between 
hydrophobicity (C log P) and steric (CMR) 
properties with biological activity. The hydrophobic 
character of a substances is crucial to how easily it 
crosses cell membrane and may also be important in 
receptor interactions. Changing substituent on a drug 
may well have significant effect on its hydrophobic 
character and hence its biological activity. It is 
generally found that increasing the hydophobicity of 
a lead compound results in an increase in biological 
activity. This reflect the fact that drugs have to cross 
hydrophobic barriers such as cell membranes in 
order to reach their target. Even if no barriers are to 
be crossed (like in vitro studies), the drug has to 
interact with a target system such as an enzyme or 
receptor where the binding site is usually 
hydrophobic. However, the drug must be sufficiently 
lipophilic (lipid loving) to partition in the membrane 
but no so lipophilic that it stay there. This explains 
the parabolic dependence or non linear correlation of 
the activity upon ClogP 
The bulk, size and shape of a drug will influence 
how easily it can approach and interact with a 
binding site. A bulky substituent may act like a 
shield and hinder the ideal interaction between a 
drug and its binding site. Alternatively, a bulky 
substituent may help to orientate a drug properly for 
maximum binding and increase activity (Patrick, 
2005; Leach, 2001) 
The relation on physicochemical properties 
with cytotoxic activity against MONO-MAC-6 and 
MEL-JUSO occur more likely in non-linear 
regression model. They are indicated with statistical 
parameters of equation (2) showed better results than 
equation (1) neither does the equation (6) compared 
with equation (5).  Whereas relation on 
physicochemical properties with cytotoxic activity 
against RAJI cells were more likely to linear 
regression relationship, although equation (3) and (4) 
showed similar parameter r and r
2
 values but F-value 
on linear regression is greater than nonlinear 
regression. 
 
CONCLUSION  
 
In summary, we have utilized QSAR as a tool 
to determine the physicochemical parameters that 
influence induced cytotoxicity of rocaglamide 
derivatives. This study had conclusion that C log P 
and CMR of rocaglamide related with its biological 
activity. 
 
REFERENCES 
 
Bohnenstengel, F., 2000., Inhaltsstoffe aus 
tropischen Meliaceen der Gattungen Aglaia 
und Melia, dissertation, Bayerischen Julius-
Maximilians- Universität Wurzburg. 
Hansch, C., R.P Verma, 2008., A QSAR study for 
the cytotoxic activities of taxoids Against 
macrophage (MФ)-like cells, Euro, Journal 
of Med. Chem, 44, 274–279. 
Kim, S., Salim, A.A., Swanson, S.M. and Kinghorn, 
A.D., 2006, Potential of 
Cyclopenta[b]benzofurans from Aglaia 
Species in Cancer Chemotherapy, Anti-
cancer Agents in Med. Chem., 6, 319-345. 
Firdayani, et al., 2010 
Indones. J. Cancer Chemoprevent., 1(2), 129-134 
 
 
134 
 
Leach, A.R., 2001, Molecular Modelling Principles 
and Application, 2nd Ed, Pearson Prentice 
Hall, England, pp 640-718. 
Patrick, G.L., 2005, An Introduction to Medicinal 
Chemistry, 3rd Ed, Oxford Univ. Press, 
New York, pp 271-296. 
Proksch, P., Edrada, R., Ebel, R., Bohnestengel, F.I, 
and Nugroho, B.W., 2001, Chemistry and 
Biological Activity of Rocaglamide 
Derivatives and Related Compounds in 
Aglaia Species (Meliaceae), Curr Org. Chem., 
5, 923-938. 
Proksch, P., Giaisi, M., Treiber, M.K., Palfi, K., 
Merling, A., Spring, H., Krammer, P.H. and  
Weber1, M.L., 2005, Rocaglamide 
Derivatives Are Immunosuppressive 
Phytochemicals That Target NF-AT Activity 
in T Cells, The Journal of Immunology, 174, 
7075–7084. 
Tropsha, A and Golbraikh, A., 2007, Predictive 
QSAR Modeling Workflow, Model 
Applicability Domains, and Virtual 
Screening. Current Pharmaceutical Design, 13, 
3494-3504. 
 
 
 
 
